Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The HYCORE1 Trial: Hybrid Revascularization Versus Coronary Artery Bypass Grafting in Patients With Multi-vessel Coronary Artery Disease. A Randomized Clinical Trial.

NCT05504031 is registered in ClinicalTrials.gov with Rigshospitalet, Denmark as lead sponsor.

NCT NCT05504031
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05504031 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The HYCORE1 Trial: Hybrid Revascularization Versus Coronary Artery Bypass Grafting in Patients With Multi-vessel Coronary Artery Disease. A Randomized Clinical Trial.
Lead sponsor
Rigshospitalet, Denmark
Phase
Not applicable
Overall status
Not yet recruiting
Start date
July 15, 2026
Completion date
January 31, 2044
Enrollment
1,048 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease